Silicone breast implants were associated with increased rates of a variety of autoimmune complications, as well as melanoma and stillbirth — and the FDA had something to say about it.
A review of data from the FDA’s large post approval studies database found that silicone implants were linked to higher rates of Sjögren syndrome, scleroderma, rheumatoid arthritis (RA), stillbirth, and melanoma, reported Mark W. Clemens, MD, of MD Anderson Cancer Center in Houston, and colleagues, in the Annals of Surgery.
